Focal Therapy

Focal therapy for prostate cancer

The classic prostate cancer treatment (PCa) has been, until not too long ago, the complete prostate removal surgery or radical prostatectomy (RP), and radiotherapy (RT). This is due to the fact that transrectal randomised prostate biopsies did not allow real mapping of the prostate tumour affection.

This has led to two important situations. First, the inability to reliably detect those patients with non-aggressive tumours which, if left to their natural progression, would not put their lives at risk, and instead of being treated only required monitoring. Secondly, as mapping of tumour affectation was not available, it was not possible to offer the possibility of carrying out focal therapies that could avoid more aggressive surgeries and with frequent sequela.

Today, thanks to the excellent information provided by fusion biopsies, we can evaluate exactly the extent of the tumour inside the prostate, as well as its aggressiveness. This allows treating only these index lesions. These are the most important tumour lesions, which finally determine the prognosis for the disease. This is known as focal therapy.

Focal therapy allows treating only the tumour area. This procedure seems to provide the same oncologic results, but with minimal functional consequences in comparison with surgery and radiotherapy, which can lead to erectile dysfunction, urinary incontinence, and other less frequent complications, such as urinary fistulas and urethral stenosis, which may seriously deteriorate the patient’s quality of life.

Focal therapy advantages

terapia focal

In our Prostate Cancer Unit we have three sources of energy for focal therapy treatments: Cryotherapy, HIFU and Electroporation.

Each patient is subject to personalized planning and will receive the source that best suits her needs, depending on the characteristics of the tumor and the individual himself.